Clinical Trial Update: Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two fixed-dose combinations of aclidinium bromide with formoterol fumarate for chronic obstructive pulmonary disease; efficacy and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium bromide/formoterol fumarate fixed-dose combination (Aclidinium bromide/formoterol fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-11-15